↗5 Form 4 rows in the window
Covers original filings from Jul 31, 2026 to Oct 28, 2026. Older trades and amendments are in the SEC history.
$4.7MBought on the market
$0.00Sold on the market
1Companies
Oct 1, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 202620:12 | Sep 30, 2026 | HELPHelus Pharma Inc. | Chief Growth Officer, Director | A · Grant | — | +248,000 | 4,750,191 | +6% | — | ||
| Sep 11, 202609:04 | Sep 8, 2026 | HELPHelus Pharma Inc. | Chief Growth Officer | P · Buy | $12.47 | +100,000 | 4,271,252 | +2% | +$1.2M | -10.8% | -12.5% |
| Sep 11, 202609:03 | Sep 8, 2026 | HELPHelus Pharma Inc. | Chief Growth Officer | P · Buy | $12.47 | +100,000 | 4,271,252 | +2% | +$1.2M | -10.8% | -12.5% |
| Sep 10, 202606:19 | Sep 3, 2026 | HELPHelus Pharma Inc. | Chief Growth Officer | P · BuyLate 7d | $11.78 | +100,000 | 4,171,252 | +2% | +$1.2M | -15.8% | -7.4% |
| Sep 9, 202611:03 | Aug 31, 2026 | HELPHelus Pharma Inc. | Chief Growth Officer | P · BuyLate 9d | $11.59 | +90,000 | 4,071,252 | +2% | +$1.0M | -17.2% | -5.8% |